|
|
| Up One Level |
|
TopiaSearch: Health: Conditions and Diseases: Eye Disorders: Glaucoma (66)
See Also:
Xalatan (Latanoprost) Reduces Intraocular Eye Pressure Better Than Trusopt (Dorzolamide) - A study published in the British Journal of Ophthalmology about the effectiveness of this glaucoma medication. Glaucoma Service and Foundation - Resources and information about medications, support groups and awareness. National Glaucoma Research - Established by the American Health Assistance Foundation to fund research on and educate the public about glaucoma through illustrations and facts. Health Factsheets from BUPA - Explains the causes, symptoms and treatment of glaucoma. Available for down loading in Adobe acrobat format. Medbroadcast.com - Extensive data base about glaucoma, looks at what it is, the causes, diagnoses and detection, treatment and FAQs. Common Vision Condition - Glaucoma - An article about this disorder stressing the importance of regular eye examination. Wills Glaucoma - Offers information about treatments, research, symptoms, plus weekly chat meetings with a specialist from Wills Eye Hospital. About Glaucoma Resources - This site lists a selection of links to sites that will help you gain a better understanding of glaucoma and related diseases of the eye. St LukesEye.com - A graphic, description of glaucoma, its effects and treatment options. Photographic examples of various degrees of damage from elevated eye pressure. Xalatan - Doctor's Guide - Article discusses Xalatan monotherapy as an equivalent to Timolol/Dorzolamide in treating interocular pressure. Text is clinical in focus. MCW HealthLink - Listing of 4 criteria used to diagnose glaucoma. Also includes the 3 types of treatments that are currently available to those that suffer. Important Facts about Glaucoma - Large and easy to access site with considerable useful information on all aspects of open-angle glaucoma the most common case of this disease. From American Academy of Ophthalmology's medical library. Latanoprost - Pediatric Ophthalmology - Read about a study on the effectiveness of latanoprost therapy on children with glaucoma. See the methods, results, and conclusions. AAO: Combination Of Latanoprost And Timolol Superior To Each Drug Individually - Xalacom (latanoprost/timolol fixed combination, Pharmacia), recently approved in Europe for the treatment of open angle glaucoma (OAG), is more effective at lowering intra-ocular pressure than the same two drugs used separately. Latanoprost, Brimonidine Reduce Intraocular Pressure in Glaucoma - A DGReview of :"Intraocular Pressure-Lowering Effects of Latanoprost and Brimonidine Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension: A Randomized Observer-Masked. Multicenter Study" Journal of Glaucoma Ocular Hypertension Treatment - Doctor's Guide, May 8, 2002 - IOP Reduction in Patients with Glaucoma or Ocular Hypertension in New Study. Atlas of Ophthalmology Online - Glaucoma Images - Thousands of superb, high-quality glaucoma images, in topics across ophthalmology from the glaucoma section of University of Miami Bascom Palmer Eye Institute's Atlas of Ophthalmology. Glaucoma Treatment - Doctor's Guide Channels - New study finds patients intraocular pressure improved when switched to Xalatan from other monotherapy. Results--Ocular Hypertension Treatment Study (OHTS) - Researchers have discovered that eye drops used to treat elevated pressure inside the eye can be effective in delaying the onset of glaucoma. Eye Drops Delay Onset Of Glaucoma In People At Higher Risk - Researchers have discovered that eye drops used to treat high pressure inside the eye can be effective in delaying the onset of glaucoma. National Eye Institute - Facts About Glaucoma - Designed to help people with glaucoma and their families better understand the disease. It describes the causes, symptoms, diagnosis, and treatment. Contains illustrations and examples to compare with. XALATAN Used in Landmark Glaucoma Study - Pharmacia donated XALATAN (latanoprost ophthalmic solution) to the National Eye Institute for use in the landmark Ocular Hypertension Treatment Study(OHTS). ARVO - Once-Daily Fixed Combination Xalacom Compared with Twice-Daily - Xalacom (latanoprost/timolol) More Effective than Cosopt (dorzolamide/timolol) for IOP Reduction in Patients with Glaucoma or Ocular Hypertension in New Study. Glaucoma - VisionChannel - The term "glaucoma" refers to a group of conditions that exhibit a gradual loss of vision, often without symptoms. Learn about diagnosis and treatment for this condition which can lead to vision loss. Glaucoma Vision Simulator - The Glaucoma Vision Simulator approximates what sufferers of glaucoma might experience in their vision. National Eye Institute - Immediate Treatment Helps Delay Glaucoma - Read results of a 6 year study showing that early treatment can prevent vision loss. FDA Grants Xalatan (Latanoprost) Approval For Initial Treatment Of Elevated Eye Pressure - Xalatan is the first and only prostaglandin with a first-line indication for the treatment of elevated eye pressure (intraocular pressure or IOP) in all three major markets: the United States, Europe and Japan. Glaucoma Net - The Official Site of the Greek Glaucoma Society. The Ocular Hypertension Treatment Study - The OHTS was designed to determine if using eyedrop medicines to lower eye pressure prevents or delays glaucoma in people with high eye pressure. Researchers have discovered that eye drops used to treat elevated pressure inside the eye can be effective in delaying the onset of glaucoma. Coping with Glaucoma - This is a story about the "silent thief of sight", by Edith Marks, an insidious eye disease that strikes without warning, without symptoms. Glaucoma Doctors FYI - Glaucoma, a leading cause of blindness, is an eye disease that results in low vision. To prevent blindness, ask a glaucoma doctor to perform glaucoma treatment. Keep your sight - Online test for glaucoma. Check your visual field with the Peristat - a new powerful tool, clinically proven to detect glaucoma. Glaucoma Public Education Program - National Eye Institute's glaucoma education Web page. Provides online and downloadable glaucoma educational material. Alternative Medicine Eye Care - Objective is to provide a protocol to help with controlling glaucoma through nutrition and lifestyle changes, help protect optic nerves from further damage, and to eventually reduce or eliminate the need for medication if possible. Glaucoma Treatment Study Results - Randomized comparison study of the three prostaglandin analogs (Xalatan, Lumigan, and Travatan) published in the American Journal of Ophthalmology. Comparison of latanoprost (Xalatan), bimatoprost (Lumigan), and travoprost (Travatan) in patients with elevated intraocular pressure. - A 12-week, randomized, masked-evaluator multicenter study comparing the intraocular pressure (IOP)-lowering effect and safety of latanoprost (Xalatan), bimatoprost (Lumigan), and travoprost (Travatan) in patients with open-angle glaucoma (OAG) or ocular hypertension (OH). Primary open-angle glaucoma in blacks: a review - Primary open-angle glaucoma (POAG) is the most prevalent form of glaucoma and has a particularly devastating impact in blacks. Talk to Your Doctor About Glaucoma - A valuable guide that will help you prepare for a visit with your eye doctor. Appointment Questionaire - This is a printable questionnaire that you can print out and take with you to your eye exam to assure you discuss important informatiopn with your eye doctor. Eye Doctor Appointment - What to Expect - This information will help you better understand what to expect during your eye examination. About Glacoma - Information about the leading cause of preventable blindness in America. Glaucoma Risk Factors - A brief discussion about this disorder and its symptoms. A look at who is at risk, what can be done, and how often to have your eyes examined. XALATAN (latanoprost ophthalmic solution) - XALATAN Sterile Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure (high eye pressure) in patients with open-angle glaucoma or ocular hypertension. Frequency doubling technology and high-pass resolution perimetry in glaucoma and ocular hypertension - There was a strong correlation between FDT threshold C-20, FDT screening C-20-5 and HRP test results. Frequency doubling technology perimetry C-20-5 represents a good screening test for the detection of optic nerve damage in open-angle glaucoma. Four years later: A clinical update on latanoprost (Xalatan) - Almost five years have elapsed since the introduction of latanoprost on several markets and considering the large number of publications dealing with it, the authors felt that it was worth re-evaluating the drug. Recent Advances In Glaucoma Management - A summary of recent advances in the treatment and management of glaucoma by Dr. VKY Yong and Dr. PTK Chew. Comparison of contrast sensitivity, visual acuity, and humphrey visual field testing in patients with glaucoma - Investigates the relationship between large-letter contrast sensitivity, high-contrast visual acuity, and visual field defects in patients with glaucoma who have 20/40 or better visual acuity. All about High Eye Pressure and Glaucoma Treatment - Researchers have discovered that eye drops used to treat high pressure can be effective in delaying the onset of glaucoma. International Glaucoma Association - The International Glaucoma Association is a registered charity which offers advice and support to glaucoma sufferers, campaigns for improved glaucoma services for glaucoma patients and aims to increase public awareness of glaucoma. LUMIGAN (bimatoprost ophthalmic solution) - Indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular lowering medications. TRAVATAN (travopost ophthalmic solution 0.004%) - TRAVATAN is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular lowering medications. Early Glaucoma Detection - A new study shows by treating people with early stage glaucoma immediately, progression of the disease can be delayed. Early testing and treatment can literally save your sight. - An estimated 3 million to 4 million Americans have glaucoma, and half of them don't even know it.
Additional categories:
|
|
||
| Glaucoma | |||
|